Clinical Trial

Evaluating Smoking Cessation Interventions for PWH in South Africa

Study acronym: Tlogela
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The overall objective of the study is to optimize a smoking cessation treatment package for people with HIV (PWH) that can be integrated into existing HIV care in South Africa.
Trial Details
NCT Number NCT05413122
Lead Sponsor Johns Hopkins University
Collaborators: Colorado State University, New York University, Perinatal HIV Research Unit of the University of the Witswatersrand, National Cancer Institute (NCI)
Conditions Smoking Cessation, HIV, Comorbidities and Coexisting Conditions
Enrollment 660 participants
Start Date 2023-11-27
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-09